These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 34954150

  • 1. Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation.
    Zhou B, Xu M, Lu S, Liu Y, Qi L, Liu T, Tian H, Chen J, Wu D, Xu Y.
    Transplant Cell Ther; 2022 Mar; 28(3):173.e1-173.e6. PubMed ID: 34954150
    [Abstract] [Full Text] [Related]

  • 2. Haploidentical Cord Blood Transplantation with 8 mg/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg/kg Antithymocyte Globulin in the Treatment of Acute Leukemia.
    Yuan F, Li G, Li M, Wei X, Fu Y.
    Transplant Cell Ther; 2023 Dec; 29(12):771.e1-771.e10. PubMed ID: 37748539
    [Abstract] [Full Text] [Related]

  • 3. [A retrospective comparative study of haplotype hematopoietic stem cell transplantation and human leukocyte antigen-matched sibling donor hematopoietic stem cell transplantation in the treatment of acute B-lymphocyte leukemia].
    Wang ZD, Sun YQ, Yan CH, Wang FR, Mo XD, Lyu M, Zhao XS, Han W, Chen H, Chen YY, Wang Y, Xu LP, Wang YZ, Liu YR, Cheng YF, Zhang XH, Liu KY, Huang XJ, Chang YJ.
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar 14; 43(3):221-228. PubMed ID: 35405780
    [Abstract] [Full Text] [Related]

  • 4. Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation.
    Zhang Y, Wang P, Cassady K, Zou Z, Li Y, Deng X, Yang W, Peng X, Zhang X, Feng Y.
    Transpl Immunol; 2022 Jun 14; 72():101596. PubMed ID: 35390479
    [Abstract] [Full Text] [Related]

  • 5. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.
    Mo XD, Tang BL, Zhang XH, Zheng CC, Xu LP, Zhu XY, Wang Y, Liu HL, Yan CH, Chu XD, Chen H, Geng LQ, Liu KY, Sun ZM, Huang XJ.
    Int J Cancer; 2016 Nov 01; 139(9):2106-15. PubMed ID: 27356906
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
    Xue YJ, Cheng YF, Lu AD, Wang Y, Zuo YX, Yan CH, Wu J, Sun YQ, Suo P, Chen YH, Chen H, Jia YP, Liu KY, Han W, Xu LP, Zhang LP, Huang XJ.
    Biol Blood Marrow Transplant; 2019 Aug 01; 25(8):1611-1620. PubMed ID: 30537550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.
    Biol Blood Marrow Transplant; 2015 Jun 01; 21(6):1110-6. PubMed ID: 25698612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcome and Prognostic Factors of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia.
    Hu GH, Zhang XH, Liu KY, Xu LP, Wang Y, Cheng YF, Huang XJ.
    Acta Haematol; 2024 Jun 01; 147(5):534-542. PubMed ID: 38246140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
    Zhou B, Chu X, Tian H, Liu T, Liu H, Gao W, Chen S, Hu S, Wu D, Xu Y.
    Am J Hematol; 2021 Nov 01; 96(11):1461-1471. PubMed ID: 34406703
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia.
    Bai L, Zhang YZ, Yan CH, Wang Y, Xu LP, Zhang XH, Zhang LP, Huang XJ, Cheng YF.
    BMC Cancer; 2022 Aug 16; 22(1):896. PubMed ID: 35974319
    [Abstract] [Full Text] [Related]

  • 19. Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia.
    Wang J, Wang Z, Wei W, Zhang W, Zhang T, Cheng H, Fei X, Yin Y, Gu J, Yuan L.
    Biol Blood Marrow Transplant; 2019 Jan 16; 25(1):121-128. PubMed ID: 30205230
    [Abstract] [Full Text] [Related]

  • 20. Predictive Factors and Outcomes after Allogeneic Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil.
    Silva WF, Cysne DN, Kerbauy MN, Colturato I, Maia ACA, Tucunduva L, Barros GMN, Colturato VAR, Hamerschlak N, Rocha V.
    Transplant Cell Ther; 2022 Nov 16; 28(11):763.e1-763.e7. PubMed ID: 35914726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.